Olinvacimab (Anti-VEGFR2 / KDR / CD309)
Product Specifications
CAS Number
2095504-49-5
Synonyms
TTAC-0001
Target
VEGFR
Applications
Protein Tyrosine Kinase
Additionnal Information
Olinvacimab (Anti-VEGFR2 / KDR / CD309) is a fully human monoclonal antibody targeting VEGFR2. It has antiangiogenic activity and can be used for the research of recurrent glioblastoma and breast cancer. MW :146.88 KD
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400391-100 1x 100 µL
CD81 / TAPA-1 (1.3.3.22), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880050-100 1x 100 µL
IgA Secretory Component (SC05), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC941855-500 1x 500 µL
TTF-1 / NKX2.1 (Thyroid & Lung Epithelial Marker) (NX2.1/1855R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681993-100 1x 100 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1993), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680872-100 1x 100 µL
Retinol Binding Protein-1 (RBP/872), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details